Tenax Therapeutics (TENX) Interest Expenses (2010 - 2026)
Tenax Therapeutics (TENX) reported Interest Expenses of $69.9 million for Q1 2026, up 3662131.53% on a YoY basis from N/an in Q1 2025, and up 535.56% sequentially from $11.0 million in Q3 2025.
Tenax Therapeutics (TENX) Interest Expenses (2010 - 2026) Analysis & Trends
Tenax Therapeutics (TENX) has 16 years of Interest Expenses data on file, last reported at $69.9 million in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses rose 3662131.53% year-over-year to $69.9 million; the trailing twelve-month figure through Mar 2026 stood at $69.9 million (up 3662131.53% YoY), and the FY2025 full-year result was $50.4 million, up 20.82% from the prior year.
- Interest Expenses rose to $69.9 million in Q1 2026, from $11.0 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $69.9 million in Q1 2026 to a low of -$1000.0 in Q4 2024.
- A 5-year average of $5.5 million and a median of $16089.0 in 2023 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses slumped 135.1% in 2024 and soared 3662131.53% in 2026, its largest moves.
- Tracing TENX's Interest Expenses over 5 years: stood at $227546.0 in 2022, then plunged by 98.75% to $2849.0 in 2023, then tumbled by 135.1% to -$1000.0 in 2024, then jumped by 1100100.0% to $11.0 million in 2025, then jumped by 535.56% to $69.9 million in 2026.
- Business Quant data shows TENX's Interest Expenses at $69.9 million in Q1 2026, $11.0 million in Q3 2025, and $2000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Tenax Therapeutics | 655.78 Mn | 655.78 Mn | - | 69.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.91 Mn |
| Mar 31, 2026 | 69.91 Mn |
| Sep 30, 2025 | 11.00 Mn |
| Sep 30, 2025 | 11.00 Mn |
| Jun 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 1,909.00 |
| Mar 31, 2025 | 1,909.00 |
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Dec 31, 2023 | 2,849.00 |
| Dec 31, 2023 | 2,849.00 |
| Sep 30, 2023 | 16,089.00 |
| Sep 30, 2023 | 16,089.00 |